Weipert Kay Felix, Hutter Julie, Kuniss Malte, Kahle Patrick, Yogarajah Joerg, Hain Andreas, Sperzel Johannes, Berkowitsch Alexander, Hamm Christian W, Neumann Thomas
Department of Cardiology, Kerckhoff Heart Center, 61231 Bad Nauheim, Germany.
German Center for Cardiovascular Research (DZHK), Rhein-Main Partner Site, 61231 Bad Nauheim, Germany.
J Clin Med. 2024 Feb 16;13(4):1118. doi: 10.3390/jcm13041118.
: Noninvasive mapping allows the identification of patient-specific atrial rotational activity (RA) that might play a key role in the perpetuation of persistent atrial fibrillation (PsAF). So far, the impact of pulmonary vein isolation by cryoballoon (Cryo-PVI) on RA is unclear. Moreover, the long-term effect of periprocedural termination of AF during the ablation procedure is controversial. : Noninvasive electrocardiographic mapping with a 252-electrode vest was performed in 42 patients with PsAF. After the first analysis, Cryo-PVI was performed. The RA was analyzed again and then targeted by radiofrequency catheter ablation. The primary clinical endpoint was periprocedural termination of AF. The secondary endpoint was freedom from any atrial arrhythmia >30 s during a 12-month follow-up. : In 33 patients (79%), right atrial RA was identified leading to biatrial ablation, and nine patients (21%) had left atrial RA only. Twelve patients (28.6%) converted from AF to sinus rhythm (SR) (Group A). Thirteen patients (30.9%) converted to atrial tachycardia (AT) (Group B). In 17 patients (40.5%), AF was not terminated by ablation (Group C). After a mean follow-up time of 13.8 months, 26 patients were free from AF and AT (61.9%). In terms of rhythm, control Group A (75%) and B (83.3%) showed higher success rates than Group C (33.3%) ( < 0.01). Cryo-PVI had no substantial impact on RA. : The RA-based ablation approach showed acceptable success rates. Periprocedural termination of AF had a positive predictive impact on the outcome. No difference was observed between conversion to SR or to AT. Cryo-PVI had no impact on RA.
无创标测能够识别特定患者的心房旋转活动(RA),其可能在持续性房颤(PsAF)的持续存在中起关键作用。到目前为止,冷冻球囊肺静脉隔离术(Cryo-PVI)对RA的影响尚不清楚。此外,消融过程中围手术期房颤终止的长期效果存在争议。
对42例PsAF患者进行了使用252电极背心的无创心电图标测。首次分析后,进行Cryo-PVI。再次分析RA,然后通过射频导管消融术对其进行靶向治疗。主要临床终点是围手术期房颤终止。次要终点是在12个月随访期间无任何持续超过30秒的房性心律失常。
33例患者(79%)识别出右心房RA,导致双房消融,9例患者(21%)仅存在左心房RA。12例患者(28.6%)从房颤转为窦性心律(SR)(A组)。13例患者(30.9%)转为房性心动过速(AT)(B组)。17例患者(40.5%)房颤未通过消融终止(C组)。平均随访13.8个月后,26例患者无房颤和AT(61.9%)。在节律控制方面,A组(75%)和B组(83.3%)的成功率高于C组(33.3%)(P<0.01)。Cryo-PVI对RA没有实质性影响。
基于RA的消融方法显示出可接受的成功率。围手术期房颤终止对结局有积极的预测作用。转为SR或AT之间未观察到差异。Cryo-PVI对RA没有影响。